This trial is testing a new cancer treatment that uses sound waves and a light-sensitizing drug. Researchers want to see if it is safe and if it works on brain cancer.
2 Primary · 8 Secondary · Reporting Duration: 24 months
30 Total Participants · 6 Treatment Groups
Primary Treatment: SONALA-001(ALA) and MR-Guided Focused Ultrasound device (MRgFUS) · No Placebo Group · Phase < 1
Age 18+ · All Participants · 10 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: